When inhibiting the K63-mediated autoubiquitination, the binding of TRAF6 and TAK1 is inhibited, which abrogates IL-1β-induced IL-6 and IL-8 synthesis in RA-FLS. The gene discussed is CXCL8; the disease is rheumatoid arthritis.